Related references
Note: Only part of the references are listed.Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
Rie Suganuma et al.
PEDIATRIC BLOOD & CANCER (2013)
MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas
Ruimin Huang et al.
FASEB JOURNAL (2011)
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma
Karel Zitterbart et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann et al.
GENOME BIOLOGY (2008)
Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: Results of patients treated in the prospective multicenter trial HIT'91
Stefan Rutkowski et al.
CLINICAL CANCER RESEARCH (2007)
Pathology of peripheral neuroblastic tumors: Significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma
Tamas Tornoczky et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
c-Myc overexpression causes anaplasia in medulloblastoma
D Stearns et al.
CANCER RESEARCH (2006)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Enlarged and prominent nucleoli may be indicative of MYCN amplification - A study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index
C Kobayashi et al.
CANCER (2005)
Large cell neuroblastoma -: A distinct phenotype of neuroblastoma with aggressive clinical behavior
T Tornóczky et al.
CANCER (2004)
Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels
A Arabi et al.
JOURNAL OF CELL SCIENCE (2003)
Advances in the diagnosis and treatment of neuroblastoma
JL Weinstein et al.
ONCOLOGIST (2003)
Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups
IM Ambros et al.
CANCER (2002)
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: A children's cancer group study
CA Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
